Literature DB >> 10382943

Influence of perioperative whole blood transfusions on lymphocyte subpopulations in patients with stage II breast cancer.

A Eroğlu1, H Canpinar, E Kansu.   

Abstract

Preliminary reports have suggested an adverse relationship between blood transfusion and survival after surgery in patients with solid tumour. One might postulate that from these studies, perioperative blood transfusions alter host immune defences. We therefore examined the influence of homologous whole blood transfusion on circulating lymphocyte subpopulations in transfused patients compared with non-transfused patients. Fifty-one women with Stage II breast cancer who underwent surgical procedures were studied. Patients were classified into two groups on the basis of whether or not they had received blood transfusion. The lymphocyte subpopulations were analyzed by flow cytometry before cancer surgery and three weeks after the operation. CD3+, CD4+, CD8+, and CD20+ cells as the lymphocyte subsets were quantitated using appropriate monoclonal antibodies. No significant differences between pre- and postoperative lymphocyte subset levels were seen in non-transfused patients. However, there was a statistically significant increase in the CD8+ cell count; decreasing CD4+ cell count and decreased CD3+ cells levels were observed in the transfused group (P < 0.05). Although these early results of the study suggest that the blood transfusions could be associated with alterations in lymphocyte populations, additional studies are needed to elucidate the possible mechanism of the transfusion-induced immunological modulations.

Entities:  

Mesh:

Year:  1999        PMID: 10382943     DOI: 10.1007/bf02787359

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  34 in total

Review 1.  Transfusion-induced immunomodulation following cancer surgery: fact or fiction?

Authors:  V Lapierre; A Aupérin; P Tiberghien
Journal:  J Natl Cancer Inst       Date:  1998-04-15       Impact factor: 13.506

2.  The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma.

Authors:  T Wobbes; K H Joosen; H H Kuypers; G I Beerthuizen; G M Theeuwes
Journal:  Dis Colon Rectum       Date:  1989-09       Impact factor: 4.585

3.  Effect of blood transfusions on subsequent kidney transplants.

Authors:  G Opelz; D P Sengar; M R Mickey; P I Terasaki
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

4.  Blood transfusion and tumour growth: evidence from laboratory animals.

Authors:  D M Francis; B K Shenton
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

5.  Red blood cells for cancer patients.

Authors:  C L Gantt
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

6.  Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region.

Authors:  J H Allema; M E Reinders; T M van Gulik; M J Koelemay; D J Van Leeuwen; L T de Wit; D J Gouma; H Obertop
Journal:  Cancer       Date:  1995-04-15       Impact factor: 6.860

7.  Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.

Authors:  J Kaplan; S Sarnaik; J Gitlin; J Lusher
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

8.  Immune functions and the prognosis of patients with solid tumours.

Authors:  E Nordman; I Lehto; A Toivanen
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

9.  The association of perioperative blood transfusion with colorectal cancer recurrence.

Authors:  P I Tartter
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

10.  Immunologic responsiveness of patients with cancer: relationship to tumor type, stage and prognosis.

Authors:  L J Humphrey; M A Humphrey; O Singla; F J Volenec
Journal:  Ann Surg       Date:  1981-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.